关注
david adams
david adams
在 aphp.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis
D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ...
New england journal of medicine 379 (1), 11-21, 2018
24972018
Inotersen treatment for patients with hereditary transthyretin amyloidosis
MD Benson, M Waddington-Cruz, JL Berk, M Polydefkis, PJ Dyck, ...
New England Journal of Medicine 379 (1), 22-31, 2018
12662018
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
T Coelho, D Adams, A Silva, P Lozeron, PN Hawkins, T Mant, J Perez, ...
New England Journal of Medicine 369 (9), 819-829, 2013
10692013
Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders
R Rupprecht, V Papadopoulos, G Rammes, TC Baghai, J Fan, N Akula, ...
Nature reviews Drug discovery 9 (12), 971-988, 2010
10052010
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 …
VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ...
The lancet Respiratory medicine 9 (12), 1407-1418, 2021
6842021
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised …
P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ...
The Lancet 389 (10086), 2317-2327, 2017
4552017
Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study
SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ...
Circulation 139 (4), 431-443, 2019
4312019
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological …
D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ...
The Lancet 392 (10163), 2441-2451, 2018
3712018
Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy
C Bouchard, C Lacroix, V Plante, D Adams, F Chedru, JM Guglielmi, ...
Neurology 52 (3), 498-498, 1999
3531999
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
D Adams, H Koike, M Slama, T Coelho
Nature Reviews Neurology 15 (7), 387-404, 2019
3492019
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
OB Suhr, T Coelho, J Buades, J Pouget, I Conceicao, J Berk, H Schmidt, ...
Orphanet journal of rare diseases 10, 1-9, 2015
3402015
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
D Adams, D Samuel, C Goulon-Goeau, M Nakazato, PMP Costa, C Feray, ...
Brain 123 (7), 1495-1504, 2000
2882000
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)
V Planté-Bordeneuve, A Ferreira, T Lalu, C Zaros, C Lacroix, D Adams, ...
Neurology 69 (7), 693-698, 2007
2642007
First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
D Adams, OB Suhr, E Hund, L Obici, I Tournev, JM Campistol, MS Slama, ...
Current opinion in neurology 29, S14-S26, 2016
2592016
Evolving landscape in the management of transthyretin amyloidosis
PN Hawkins, Y Ando, A Dispenzeri, A Gonzalez-Duarte, D Adams, ...
Annals of medicine 47 (8), 625-638, 2015
2552015
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression
EB Brown, SL McElroy, PE Keck Jr, A Deldar, DH Adams, M Tohen, ...
Journal of Clinical Psychiatry 67 (7), 1025-1033, 2006
2502006
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
D Adams, Y Ando, JM Beirão, T Coelho, MA Gertz, JD Gillmore, ...
Journal of neurology 268, 2109-2122, 2021
2272021
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management …
Y Parman, D Adams, L Obici, L Galán, V Guergueltcheva, OB Suhr, ...
Current opinion in neurology 29, S3-S13, 2016
2242016
Multifocal motor neuropathy with conduction block: a study of 24 patients.
P Bouche, A Moulonguet, AB Younes-Chennoufi, D Adams, N Baumann, ...
Journal of Neurology, Neurosurgery & Psychiatry 59 (1), 38-44, 1995
2231995
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ...
The Lancet 395 (10217), 53-64, 2020
2222020
系统目前无法执行此操作,请稍后再试。
文章 1–20